2018 대한부정맥학회 심방세동 환자의 심박수 조절 지침

키워드

참고문헌 (50)

1. Nikolaidou T, "Chronic atrial fibrillation: a systematic review of medical heart rate control management", Postgrad Med J, 85, pp.303~312 (2009)[DOI]
2. Heist EK, "Rate control in atrial fibrillation: targets, methods, resynchronization considerations", Circulation, 124, pp.2746~2755 (2011)[DOI]
3. Schreck DM, "Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin", Ann Emerg Med, 29, pp.135~140 (1997)[DOI]
4. Siu CW, "Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation", Crit Care Med, 37, pp.2174~2179 (2009)[DOI]
5. Tisdale JE, "A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery", Am Heart J, 135(5), pp.739~747 (1998)[DOI]
6. Scheuermeyer FX, "Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness", Acad Emerg Med, 20, pp.222~230 (2013)[DOI]
7. Platia EV, "Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter", Am J Cardiol, 63, pp.925~929 (1989)[DOI]
8. Ellenbogen KA, "A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study", J Am Coll Cardiol, 18, pp.891~897 (1991)[DOI]
9. Steinberg JS, "Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise", J Am Coll Cardiol, 9, pp.405~411 (1987)[DOI]
10. Goldstein RE, "Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group", Circulation, 83, pp.52~60 (1991)[DOI]
11. Clemo HF, "Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias", Am J Cardiol, 81, pp.594~598 (1998)[DOI]
12. Delle Karth G, "Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias", Crit Care Med, 29, pp.1149~1153 (2001)[DOI]
13. Hou ZY, "Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study", Eur Heart J, 16, pp.521~528 (1995)[DOI]
14. Kotecha D, "Efficacy of <TEX>${\beta}$<", TEX> blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis, 2014, pp.384, 2235~2243
15. Yu HT, "Outcomes of rate-control treatment in patients with atrial fibrillation and heart failure-a nationwide cohort study", Circ J, 82, pp.652~658 (2018)[DOI]
16. Kotecha D, "Effect of age and sex on efficacy and tolerability of <TEX>${\beta}$<", TEX> blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis, 2016, pp.353, i1855~
17. Ulimoen SR, "Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation", Am J Cardiol, 111, pp.225~230 (2013)[DOI]
18. 김민석, "Korean Guidelines for Diagnosis and Management of Chronic Heart Failure", Korean Circulation Journal, 47(5), pp.555~643 (2017), 대한심장학회[DOI]
19. Elkayam U, "Calcium channel blockers in heart failure", J Am Coll Cardiol, 22(4 Suppl A), pp.139A~144A (1993)[DOI]
20. Ulimoen SR, "Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation", Eur Heart J, 35, pp.517~524 (2014)[DOI]
21. Digitalis Investigation Group, "The effect of digoxin on mortality and morbidity in patients with heart failure", N Engl J Med, 336, pp.525~533 (1997)[DOI]
22. Ahmed A, "Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial", Circulation, 114, pp.397~403 (2006)[DOI]
23. Turakhia MP, "Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study", J Am Coll Cardiol, 64, pp.660~668 (2014)[DOI]
24. Hallberg P, "Digoxin and mortality in atrial fibrillation: a prospective cohort study", Eur J Clin Pharmacol, 63, pp.959~971 (2007)[DOI]
25. Whitbeck MG, "Increased mortality among patients taking digoxin--analysis from the AFFIRM study", Eur Heart J, 34, pp.1481~1488 (2013)[DOI]
26. Gheorghiade M, "Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial", Eur Heart J, 34, pp.1489~1497 (2013)[DOI]
27. Flory JH, "Observational cohort study of the safety of digoxin use in women with heart failure", BMJ Open, 2, pp.e000888~ (2012)[DOI]
28. Allen LA, "Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort", J Am Coll Cardiol, 65, pp.2691~2698 (2015)[DOI]
29. Ziff OJ, "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data", BMJ, 351, pp.h4451~ (2015)
30. Khand AU, "Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?", J Am Coll Cardiol, 42, pp.1944~1951 (2003)[DOI]
31. Farshi R, "Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens", J Am Coll Cardiol, 33, pp.304~310 (1999)[DOI]
32. Koh KK, "Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation", Am J Cardiol, 75, pp.88~90 (1995)[DOI]
33. Tsuneda T, "Rate control and quality of life in patients with permanent atrial fibrillation: the Quality of Life and Atrial Fibrillation (QOLAF) Study", Circ J, 70, pp.965~970 (2006)[DOI]
34. Van Gelder IC, "Lenient versus strict rate control in patients with atrial fibrillation", N Engl J Med, 362, pp.1363~1373 (2010)[DOI]
35. Groenveld HF, "The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study", J Am Coll Cardiol, 58, pp.1795~1803 (2011)[DOI]
36. Van Gelder IC, "Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies", Europace, 8, pp.935~942 (2006)[DOI]
37. Olshansky B, "The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation", J Am Coll Cardiol, 43, pp.1201~1208 (2004)[DOI]
38. Kirchhof P, "Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)", Europace, 16, pp.6~14 (2014)[DOI]
39. Li SJ, "Prognostic significance of resting heart rate and use of beta-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry", Circ Heart Fail, 8, pp.871~879 (2015)[DOI]
40. Queiroga A, "Ablate and pace revisited: long term survival and predictors of permanent atrial fibrillation", Heart, 89, pp.1035~1038 (2003)[DOI]
41. Lim KT, "Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial", Europace, 9, pp.498~505 (2007)[DOI]
42. Geelen P, "Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction", Pacing Clin Electrophysiol, 20(2), pp.343~348 (1997)[DOI]
43. Wang RX, "Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation", Heart Rhythm, 10, pp.696~701 (2013)[DOI]
44. Chatterjee NA, "Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review", Circ Arrhythm Electrophysiol, 5, pp.68~76 (2012)[DOI]
45. Bradley DJ, "Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation", Clin Pharmacol Ther, 81, pp.284~287 (2007)[DOI]
46. Wood MA, "Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis", Circulation, 101, pp.1138~1144 (2000)[DOI]
47. Ozcan C, "Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation", N Engl J Med, 344, pp.1043~1051 (2001)[DOI]
48. Hess PL, "Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and metaanalysis", Curr Cardiol Rep, 15, pp.330~ (2013)[DOI]
49. Hoppe UC, "Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure", Circulation, 114, pp.18~25 (2006)[DOI]
50. Chatterjee NA, "Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode", Eur J Heart Fail, 14, pp.661~667 (2012)[DOI]

관련 논문AI추천